We are thrilled to announce data from three presentations at the TIDES: Oligonucleotides and Peptide Therapeutics Europe annual meeting showcasing our first-in-class enzymatic synthesis capabilities! In summary, Codexis demonstrated: ✅ The first-ever enzymatic synthesis of an approved siRNA therapeutic, ✅ Similar outcomes utilizing three routes of enzymatic ligation to produce the same siRNA asset, ✅ And, in a joint poster with Bachem, the superiority of the Company's double-stranded RNA ligases compared to wild-type enzymes Read our press release for more information on the full data announcement. Link: https://bit.ly/3USknBk #siRNA #enzymaticsynthesis #TIDESEurope #RNAitherapeutics
Codexis, Inc.
Biotechnology Research
Redwood City, CA 18,746 followers
We deliver exquisite enzymes for the betterment of human health.
About us
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
- Website
-
http://www.codexis.com
External link for Codexis, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Redwood City, CA
- Type
- Public Company
- Founded
- 2002
- Specialties
- Biocatalysis, Directed Evolution, Enzyme Optimization, Biocatalysts, Enzyme Engineering, Life Sciences, Enzyme replacement therapy, API manufacturing, Pharmaceutical manufacturing, RNA manufacturing, RNA detection, Oligo synthesis, Pharma Biocatalysis, and Oligonucleotides
Locations
-
Primary
200 Penobscot Drive
Redwood City, CA 94063, US
Employees at Codexis, Inc.
-
Lata Sircar
Senior Finance Leader | Business Partner | Process Improvement | Change Management
-
Lauren Rose Musto
VP, Communications @ Codexis | LinkedIn Top Voice | Corporate Storytelling | Branding | Engagement | Patient Advocacy | Speaker
-
David Smith
-
Antoinette Sero
Associate Scientist
Updates
-
🎆Wishing you many adventures and much success in 2025! Happy New Year!🥂 #happynewyear #2025
-
It's one month post-TIDES and we're still on cloud nine from all the great conversations had and data presented.🔥 Check out this recap below and let us know if you spot Codexis' very own Mathew Miller during his TIDES Talk! Missed our presentations? No problem! Click the link below for the slides from our three presentations, including Derek Gauntlett's talk demonstrating our successful completion of four routes of enzymatic synthesis for inclisiran, and our joint poster with Bachem on enzymatic ligation. #RNAi #TIDESEurope #enzymeengineering Link to Presentations: https://bit.ly/4fpwNbi
🚨 TIDES Europe 2024: How Industry Leaders Made an Impact 🚨 This year’s event brought together 700+ attendees, 90+ exhibitors, and 120+ speakers to drive innovation and collaboration in oligonucleotide, peptide, and mRNA therapeutics. A huge shoutout to our amazing sponsors—Codexis, Inc., ST PHARM, BioSpring GmbH, PolyPeptide Group, WuXi AppTec/WuXi Chemistry, and many more—for showcasing cutting-edge solutions and making a real impact. 🎥 Don’t just take our word for it! Hear the success stories from our sponsors & exhibitors: DuPont, ChemGenes, TriLink BioTechnologies, part of Maravai LifeSciences and Fluid Air. 📩 Let’s talk sponsorship opportunities for 2025! https://lnkd.in/e9AzY63Y #TIDES2024 #TIDES2025 #SponsorshipOpportunities #BiotechInnovation
-
It's the most wonderful time of the year - the season of giving! We always enjoy partnering with Family Giving Tree for the work they do supporting families and children near our HQ in Redwood City, CA. A big part of their programming is providing wrapped holiday gifts to children in the Bay Area. We were delighted to have a group of Codexians head to their facilities to help sort gifts on the busiest drop day of the year and bring a little holiday cheer to our local community. Thanks to our Activities Committee for organizing and to Vesna, Michael, Ravi, Marissa, Dom, Careyna, Trish and Margie for volunteering their time to support a great cause and truly live our Community value. 💝 #community #giveback #payitforward
-
We were delighted to sponsor the 2024 Biomanufacturing World Summit last month! Our SVP of Research, Dr. Stefan Lutz, gave a presentation on how enzyme technology is revolutionizing RNAi therapeutics. His talk is now available on demand at the below link! Thanks to Executive Presence for pulling together such an insightful congress! #biomanufacturing #RNAitherapeutics #enzymes Link to Replay: https://bit.ly/4fktVgc
-
🎬 And that's a wrap! TIDES Europe 2024 has come to a close! Huge thank you to the Codexis team who traveled in from San Francisco and beyond for this incredible event in Hamburg, Germany. And a special thanks to TIDES: Oligonucleotides and Peptide Therapeutics for putting on another wonderful congress. Here are some of our favorite pictures from the week. Check the link in comments for our press release, which highlights the game-changing enzymatic synthesis data we presented. 🔥🔥🔥 Wishing all attendees safe travels home! ✈ ***** The Team (from L to R): Britton Jimenez, Mark Hochstetler, Jean Shieh, Justin Dassie, Derek Gauntlett, Alison Moore, Stefan Lutz, Mathew Miller, Kevin Norrett, Ushati Das Chakravarty, PhD and David Entwistle
-
Today, Derek Gauntlett is giving an oral presentation highlighting the latest advancements of our ECO Synthesis manufacturing platform! Our team is also at Booth 709 to discuss how our enzymatic synthesis capabilities can support your RNAi therapeutics development. Follow along for more updates on Codexis, Inc., ECO Synthesis and siRNA manufacturing. #RNAi #oligonucleotides #enzymeengineering #TIDESEurope
Similar pages
Browse jobs
Stock
CDXS
NASDAQ
20 minutes delay
$5.00
0.23 (4.822%)
- Open
- 4.86
- Low
- 4.78
- High
- 5.085
Data from Refinitiv
See more info on